Literature DB >> 19413571

The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS.

W M Connelly1, F C Shenton, N Lethbridge, R Leurs, H J Waldvogel, R L M Faull, G Lees, P L Chazot.   

Abstract

BACKGROUND AND
PURPOSE: The histamine H4 receptor is the most recently identified of the G protein-coupled histamine receptor family and binds several neuroactive drugs, including amitriptyline and clozapine. So far, H4 receptors have been found only on haematopoietic cells, highlighting its importance in inflammatory conditions. Here we investigated the possibility that H4 receptors may be expressed in both the human and mouse CNS.
METHODS: Immunological and pharmacological studies were performed using a novel anti-H4 receptor antibody in both human and mouse brains, and electrophysiological techniques in the mouse brain respectively. Pharmacological tools, selective for the H4 receptor and patch clamp electrophysiology, were utilized to confirm functional properties of the H4 receptor in layer IV of the mouse somatosensory cortex.
RESULTS: Histamine H4 receptors were prominently expressed in distinct deep laminae, particularly layer VI, in the human cortex, and mouse thalamus, hippocampal CA4 stratum lucidum and layer IV of the cerebral cortex. In layer IV of the mouse somatosensory cortex, the H4 receptor agonist 4-methyl histamine (20 micromol x L(-1)) directly hyperpolarized neurons, an effect that was blocked by the selective H4 receptor antagonist JNJ 10191584, and promoted outwardly rectifying currents in these cells. Monosynaptic thalamocortical CNQX-sensitive excitatory postsynaptic potentials were not altered by 4-methyl histamine (20 micromol x L(-1)) suggesting that H4 receptors did not act as hetero-receptors on thalamocortical glutamatergic terminals. CONCLUSIONS AND IMPLICATIONS: This is the first demonstration that histamine H4 receptors are functionally expressed on neurons, which has major implications for the therapeutic potential of these receptors in neurology and psychiatry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19413571      PMCID: PMC2697783          DOI: 10.1111/j.1476-5381.2009.00227.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

1.  Immunological identification of the mammalian H3 histamine receptor in the mouse brain.

Authors:  P L Chazot; V Hann; C Wilson; G Lees; C L Thompson
Journal:  Neuroreport       Date:  2001-02-12       Impact factor: 1.837

2.  Structure and expression of the human histamine H4-receptor gene.

Authors:  F Cogé; S P Guénin; H Rique; J A Boutin; J P Galizzi
Journal:  Biochem Biophys Res Commun       Date:  2001-06-08       Impact factor: 3.575

3.  Thalamocortical responses of mouse somatosensory (barrel) cortex in vitro.

Authors:  A Agmon; B W Connors
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

Review 4.  The physiology of brain histamine.

Authors:  R E Brown; D R Stevens; H L Haas
Journal:  Prog Neurobiol       Date:  2001-04       Impact factor: 11.685

5.  Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes.

Authors:  T Oda; N Morikawa; Y Saito; Y Masuho; S Matsumoto
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

6.  Cloning and characterization of a novel human histamine receptor.

Authors:  K L Morse; J Behan; T M Laz; R E West; S A Greenfeder; J C Anthes; S Umland; Y Wan; R W Hipkin; W Gonsiorek; N Shin; E L Gustafson; X Qiao; S Wang; J A Hedrick; J Greene; M Bayne; F J Monsma
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

7.  Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow.

Authors:  C Liu; X Ma; X Jiang; S J Wilson; C L Hofstra; J Blevitt; J Pyati; X Li; W Chai; N Carruthers; T W Lovenberg
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

8.  Cloning, expression, and pharmacological characterization of a novel human histamine receptor.

Authors:  Y Zhu; D Michalovich; H Wu; K B Tan; G M Dytko; I J Mannan; R Boyce; J Alston; L A Tierney; X Li; N C Herrity; L Vawter; H M Sarau; R S Ames; C M Davenport; J P Hieble; S Wilson; D J Bergsma; L R Fitzgerald
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

9.  Discovery of a novel member of the histamine receptor family.

Authors:  T Nguyen; D A Shapiro; S R George; V Setola; D K Lee; R Cheng; L Rauser; S P Lee; K R Lynch; B L Roth; B F O'Dowd
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

10.  Genomic organization and characterization of splice variants of the human histamine H3 receptor.

Authors:  F Cogé; S P Guénin; V Audinot; A Renouard-Try; P Beauverger; C Macia; C Ouvry; N Nagel; H Rique; J A Boutin; J P Galizzi
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

View more
  53 in total

1.  Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system.

Authors:  Roxana del Rio; Rajkumar Noubade; Naresha Saligrama; Emma H Wall; Dimitry N Krementsov; Matthew E Poynter; James F Zachary; Robin L Thurmond; Cory Teuscher
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

2.  Well characterized antihistamine 4 receptor antibodies contribute to current knowledge of the expression and biology of the human and murine histamine 4 receptor.

Authors:  Ralf Gutzmer; Thomas Werfel; Wolfgang Bäumer; Manfred Kietzmann; Paul L Chazot; Rob Leurs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-14       Impact factor: 3.000

3.  Advances in histamine pharmacology reveal new drug targets.

Authors:  Paul L Chazot
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 4.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

5.  Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.

Authors:  C Ballerini; A Aldinucci; I Luccarini; A Galante; C Manuelli; P Blandina; M Katebe; P L Chazot; E Masini; M B Passani
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

6.  Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.

Authors:  Narumi Hashikawa-Hobara; Noel Yan-Ki Chan; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2011-10-19       Impact factor: 4.030

7.  Expression and function of histamine H4 receptor in mouse splenic dendritic cells.

Authors:  T Simon; I Jelinek; Gy Apponyi; V László; E Rajnavölgyi; A Falus
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

8.  Histamine H4-receptor expression in the brain?

Authors:  Erich H Schneider; Detlef Neumann; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-26       Impact factor: 3.000

9.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

10.  Postsynaptic mechanisms underlying the excitatory action of histamine on medial vestibular nucleus neurons in rats.

Authors:  Xiao-Yang Zhang; Lei Yu; Qian-Xing Zhuang; Shi-Yu Peng; Jing-Ning Zhu; Jian-Jun Wang
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.